IPS Bio Co.
Latest round
- Series A
Last raised
- May 2021
Total raised
- $7.1M
Investors
- 3
About IPS Bio Co.
, Ltd. operates as a biotechnology company that engages in the research and development of stem cell solutions and therapies aimed at treating rare diseases., Ltd. The firm’s partners include CHDI Foundation, Roche, the University of Rochester Medical Center, Novartis, etc. The company offers novel treatments and therapies for intractable and degenerative neurological diseases using iPS stem cells. The company develops cell therapies and small molecules to treat diseases like strokes, Huntington’s disease, Alzheimer’s, etc.
Who invested in IPS Bio Co.
3 investors across 1 round
See all investors in IPS Bio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 17, 2021
Amount
$7.1M
Investors
Questions about IPS Bio Co.
Who invested in IPS Bio Co.?
IPS Bio Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IPS Bio Co. raised?
IPS Bio Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IPS Bio Co. last raise money?
IPS Bio Co.'s most recent round on record is a Series A, in May 2021.
What does IPS Bio Co. do?
IPS Bio Co. is a biotechnology company.
Where is IPS Bio Co. headquartered?
IPS Bio Co. is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like IPS Bio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at IPS Bio Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like IPS Bio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.